PT Pyridam Farma Tbk
PYFA
Rank in Stocks
#20973
PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the... PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the development, production, and distribution of a broad spectrum of health-related products. Its offerings encompass pharmaceuticals, antibiotics, essential vitamins, dietary supplements, and traditional herbal remedies. The company's operations are divided into two main segments: Pharmaceutical Products and Contract Manufacturing Services, and Medical Device Products. Within its medical device division, the firm provides a variety of instruments and consumables. These include clinical waste management items, collection swabs and tubes, innerbox DCA, KF94 masks, parafilm, PCR extraction kits and their accompanying machinery, specimen bags, sterile containers, and tube stoppers. Furthermore, PT Pyridam Farma markets a diverse collection of skincare products, such as Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel. Its pharmaceutical portfolio addresses numerous therapeutic areas, including digestive and metabolic health, blood and blood-forming organ conditions, cardiovascular disorders, dermatological ailments, genitourinary system and sex hormone regulation, systemic corticosteroids, systemic antibacterial treatments, sensory organ issues, as well as musculoskeletal, nervous, and respiratory system conditions. Beyond medicinal lines, the company also develops and sells dietary supplements and preventive consumer health items, notably energy drinks and various healthy ready-to-consume beverages. A key area of its strategic focus involves conducting extensive research and development in biotechnology, life sciences, and medical science. Established in 1976, PT Pyridam Farma Tbk is headquartered in Jakarta, Indonesia.
Share Price
$0.00670277
Last synced: 2026-11-10
Market Cap
$75.32M
Change (1 day)
2.54%
Change (1 year)
-80.01%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Pyridam Farma Tbk (PYFA)
Category
Healthcare
EPS for PT Pyridam Farma Tbk (PYFA)
EPS as of June 2026 TTM: $0.00
According to PT Pyridam Farma Tbk's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for PT Pyridam Farma Tbk from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -16.67% |
| 2025 | 0.00 | -16.67% |
| 2024 | 0.00 | 9.09% |
| 2023 | 0.00 | -130.99% |
| 2022 | $0.01 | 3,450.00% |
| 2021 | 0.00 | -66.67% |
| 2020 | 0.00 | 100.00% |
| 2019 | 0.00 | 50.00% |
| 2018 | 0.00 | -80.00% |
| 2017 | 0.00 | 42.86% |
| 2016 | 0.00 | 75.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | -60.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | -9.09% |
| 2011 | 0.00 | 22.22% |
| 2010 | 0.00 | 28.57% |
| 2009 | 0.00 | 75.00% |
| 2008 | 0.00 | 33.33% |
| 2007 | 0.00 | -25.00% |
| 2006 | 0.00 | 33.33% |
| 2005 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -382,535.29% |
DE
|
|
| $6.08 | -357,605.88% |
DE
|
|
| $1.55 | -91,311.76% |
JP
|
|
| $3.66 | -215,394.12% |
CH
|
|
| $0.45 | -26,570.59% |
IL
|
Questions about PT Pyridam Farma Tbk's earnings per share (EPS)
What is PT Pyridam Farma Tbk's earnings per share (EPS)?
PT Pyridam Farma Tbk's earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was PT Pyridam Farma Tbk's earnings per share (EPS) in 2025?
In 2025, PT Pyridam Farma Tbk's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has PT Pyridam Farma Tbk's earnings per share (EPS) changed since 2020?
From 2020 to 2025, PT Pyridam Farma Tbk's earnings per share (EPS) was highest in 2022 ($0.01) and lowest in 2025 (0.00).
How does PT Pyridam Farma Tbk's earnings per share (EPS) compare with similar companies?
PT Pyridam Farma Tbk's earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.